Liver Fibrosis Regression and Associated Factors in HCV Patients Treated with Direct-Acting Antiviral Agents

Liver Fibrosis Regression and Associated Factors in HCV Patients Treated with Direct-Acting Antiviral Agents

There is accumulating evidence that treatment of chronic hepatitis C (HCV) leads to improvements in liver fibrosis. We aimed to investigate the improvement in fibrosis stage following treatment with direct-acting antivirals (DAAs) and factors associated with fibrosis regression. Fibroscan<sup>...

Full description

Bibliographic Details
Main Authors: Naim Abu-Freha, Osama Abu-Kosh, David Yardeni, Yaffa Ashur, Muhammad Abu-Arar, Baha Yousef, Shulamit Monitin, Sarah Weissmann, Ohad Etzion
Format: Article
Language:English
Published: MDPI AG 2023-09-01
Series:Life
Subjects:
hepatitis C
fibrosis
regression
direct-acting antiviral
Fibroscan
Online Access:https://www.mdpi.com/2075-1729/13/9/1872

Similar Items

Similar Items